Anacor Pharmaceuticals and Medicines for Malaria project Extend Development ... MarketWatch (press release) In addition, Anacor is developing AN2718 as a topical agent product candidate for the treatment of onychomycosis and skin fungal infections, and AN2898 as a topical anti-inflammatory product candidate for the treatment of disease of the skin and atopic ... Anacor and MMV Expand concern to Enable Proof-of construct Study with ... hereditary Engineering News all iii news articles » Link To Article
No comments:
Post a Comment